V. Reinicke

533 total citations
38 papers, 409 citations indexed

About

V. Reinicke is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, V. Reinicke has authored 38 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in V. Reinicke's work include Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Viral gastroenteritis research and epidemiology (3 papers). V. Reinicke is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Viral gastroenteritis research and epidemiology (3 papers). V. Reinicke collaborates with scholars based in Denmark, Switzerland and United Kingdom. V. Reinicke's co-authors include E. Dybkjær, Carl H. Mordhorst, Erik Nordenfelt, E Nordenfelt, Hemming Poulsen, B Körner, E. Schonne, Thorkild Friis, Per Thomsen and Jens Nielsen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and American Journal of Ophthalmology.

In The Last Decade

V. Reinicke

38 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Reinicke Denmark 12 249 152 66 41 40 38 409
T Uzawa Japan 6 329 1.3× 225 1.5× 21 0.3× 54 1.3× 26 0.7× 9 456
AlfredM. Prince United States 8 304 1.2× 241 1.6× 49 0.7× 55 1.3× 13 0.3× 10 453
Y.M. Fakunle Nigeria 11 145 0.6× 97 0.6× 16 0.2× 28 0.7× 35 0.9× 27 323
Anthony N. DeMeo United States 4 162 0.7× 51 0.3× 15 0.2× 52 1.3× 26 0.7× 4 363
C. De Bac Italy 11 421 1.7× 424 2.8× 26 0.4× 108 2.6× 18 0.5× 27 542
Richard B. Capps United States 7 274 1.1× 262 1.7× 18 0.3× 97 2.4× 11 0.3× 9 428
L. B. Seeff United States 7 555 2.2× 568 3.7× 26 0.4× 91 2.2× 12 0.3× 8 693
Katsutaro Hirota Japan 10 439 1.8× 382 2.5× 32 0.5× 59 1.4× 105 2.6× 13 576
C Trépo France 11 221 0.9× 162 1.1× 15 0.2× 123 3.0× 13 0.3× 31 358
Susan U. Squier United States 5 170 0.7× 157 1.0× 15 0.2× 56 1.4× 59 1.5× 8 520

Countries citing papers authored by V. Reinicke

Since Specialization
Citations

This map shows the geographic impact of V. Reinicke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Reinicke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Reinicke more than expected).

Fields of papers citing papers by V. Reinicke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Reinicke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Reinicke. The network helps show where V. Reinicke may publish in the future.

Co-authorship network of co-authors of V. Reinicke

This figure shows the co-authorship network connecting the top 25 collaborators of V. Reinicke. A scholar is included among the top collaborators of V. Reinicke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Reinicke. V. Reinicke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elsborg, L, K. Boysen, A Bruusgaard, & V. Reinicke. (1984). Sucralfate versus placebo treatment in duodenal and prepyloric ulcer: a clinical endoscopic, double-blind controlled investigation.. PubMed. 31(6). 269–71. 7 indexed citations
2.
Mejer, Johannes & V. Reinicke. (1983). Changes in some nucleoside metabolizing enzymes of lymphocytes and granulocytes from patients with cirrhosis of the liver. Scandinavian Journal of Clinical and Laboratory Investigation. 43(3). 227–232. 1 indexed citations
3.
Thomsen, Per & V. Reinicke. (1981). Ground glass inclusions in liver cells in an alcoholic treated with cyanamide (Dipsan). Liver International. 1(1). 67–73. 11 indexed citations
4.
Elsborg, L, et al.. (1981). Endoscopie Retrograde Pancreatography and the Exocrine Pancreatic Function in Chronic Alcoholism. Scandinavian Journal of Gastroenterology. 16(7). 941–944. 9 indexed citations
5.
Aach, Richard D., Harrison Alter, L. F. Barker, et al.. (1981). Should Donors with a History of Jaundice Still be Rejected?. Vox Sanguinis. 41(2). 110–127. 2 indexed citations
6.
Alter, Harvey J., Lewellys F. Barker, Lewellys F. Barker, et al.. (1977). ‘How Frequent is Posttransfusion Hepatitis after the Introduction of 3rd Generation Donor Screening for Hepatitis B? What is its Probable Nature?’. Vox Sanguinis. 32(6). 346–363. 11 indexed citations
7.
Grove, O., et al.. (1976). The 1971-72 Epidemic of Acute Viral Hepatitis in Godthaab, Greenland. Scandinavian Journal of Gastroenterology. 11(3). 257–262. 2 indexed citations
8.
Fiedler, H., G. Maaß, Lacy R. Overby, et al.. (1975). BLOOD-TRANSFUSION AND PROPHYLAXIS AGAINST HEPATITIS. The Lancet. 306(7929). 329–329. 4 indexed citations
9.
Reinicke, V., et al.. (1974). Central Nervous System Affection in Connection with “Ordinary” Measles. Scandinavian Journal of Infectious Diseases. 6(2). 131–135. 2 indexed citations
10.
Reinicke, V.. (1974). Post-transfusion Hepatitis. Scandinavian Journal of Infectious Diseases. 6(3). 285–290. 21 indexed citations
11.
Nielsen, Jens, Morten H. Nielsen, & V. Reinicke. (1972). ABSENCE OF DANE PARTICLES IN AU-ANTIGEN CARRIERS WITH A HISTOLOGICALLY NORMAL LIVER. The Lancet. 300(7783). 934–934. 11 indexed citations
12.
Reinicke, V. & E. Dybkjær. (1971). LIVER DISEASE IN CARRIERS OF Au ANTIGEN. The Lancet. 298(7732). 1032–1032. 3 indexed citations
13.
Dybkjær, E., et al.. (1971). AUSTRALIA ANTIGEN AND ANTIBODY IN 10,000 DANISH BLOOD-DONORS. The Lancet. 297(7704). 860–861. 53 indexed citations
14.
Reinicke, V.. (1970). HEPATITIS-ASSOCIATED ANTIGEN IN CHRONIC LIVER DISEASE. The Lancet. 295(7638). 141–142. 26 indexed citations
15.
Reinicke, V., et al.. (1969). A Familial Epidemic of Ornithosis. Scandinavian Journal of Infectious Diseases. 1(2). 113–118. 3 indexed citations
16.
Mordhorst, Carl H., V. Reinicke, & E. Schonne. (1967). In Ovo Inhibition by Concentrated Chick Interferon of the Growth of Tric Agents. American Journal of Ophthalmology. 63(5). 1107–1109. 14 indexed citations
17.
Reinicke, V., et al.. (1965). THE INFLUENCE OF INTERFERON AND HYDROCORTISONE ON THE PRODUCTION OF INCOMPLETE INFLUENZA VIRUS IN OVO. Acta Pathologica Microbiologica Scandinavica. 63(1). 51–58. 5 indexed citations
18.
Reinicke, V.. (1965). INCREASE OF SIZE OF SINDBIS VIRUS PLAQUES DUE TO THE EFFECT OF STEROID HORMONES. Acta Pathologica Microbiologica Scandinavica. 65(4). 554–558. 1 indexed citations
19.
Reinicke, V.. (1965). THE INFLUENCE OF STEROID HORMONES AND GROWTH HORMONES ON THE PRODUCTION OF INFLUENZA VIRUS AND INTERFERON IN TISSUE CULTURE. Acta Pathologica Microbiologica Scandinavica. 64(4). 553–560. 8 indexed citations
20.
Reinicke, V.. (1964). THE INFLUENCE OF HYDROCORTISONE ON PRODUCTION OF INFLUENZA VIRUS AND INTERFERON IN OVO. Acta Pathologica Microbiologica Scandinavica. 60(4). 528–539. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026